Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street
10:21am, Tuesday, 06'th Dec 2022 The Motley Fool
Select Wall Street analysts believe these fast-growing companies could skyrocket next year.
3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street
05:21am, Tuesday, 06'th Dec 2022
Select Wall Street analysts believe these fast-growing companies could skyrocket next year.
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
03:20pm, Wednesday, 30'th Nov 2022 Zacks Investment Research
The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.
Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?
01:50pm, Wednesday, 30'th Nov 2022 Zacks Investment Research
Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
12:02pm, Wednesday, 30'th Nov 2022
The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.
IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
04:21pm, Tuesday, 29'th Nov 2022 MarketWatch
The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic.
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
05:30pm, Monday, 28'th Nov 2022 Zacks Investment Research
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
01:32pm, Monday, 28'th Nov 2022
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
Is Novavax Stock a Buy Now?
03:37pm, Saturday, 26'th Nov 2022 The Motley Fool
There's probably not much good news coming for this biotech in the near future.
Is Novavax Stock a Buy Now?
10:37am, Saturday, 26'th Nov 2022
There's probably not much good news coming for this biotech in the near future.
3 Potentially Explosive Stocks to Buy Before 2023
10:30am, Saturday, 26'th Nov 2022 The Motley Fool
These stocks suffered in 2022. And they have reason to rebound.
3 Potentially Explosive Stocks to Buy Before 2023
05:30am, Saturday, 26'th Nov 2022
These stocks suffered in 2022. And they have reason to rebound.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
02:00pm, Friday, 25'th Nov 2022 Zacks Investment Research
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:32am, Friday, 25'th Nov 2022
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novavax Stock: Buy, Sell, or Hold in 2023?
11:00am, Thursday, 24'th Nov 2022 The Motley Fool
The shares are heading for almost a 90% loss this year.
